Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 222 SEK 4.32% Market Closed
Market Cap: 30.1B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Wall Street
Price Targets

VITR Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VITR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VITR is 272.85 SEK with a low forecast of 252.5 SEK and a high forecast of 294 SEK.

Lowest
Price Target
252.5 SEK
14% Upside
Average
Price Target
272.85 SEK
23% Upside
Highest
Price Target
294 SEK
32% Upside
Vitrolife AB Competitors:
Price Targets
SVE
Synthaverse SA
52% Upside
OPK
OPKO Health Inc
153% Upside
GBIO
Generation Bio Co
441% Upside
HOWL
Werewolf Therapeutics Inc
548% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
32% Upside
CPRX
Catalyst Pharmaceuticals Inc
53% Upside
145020
Hugel Inc
40% Upside
TGTX
TG Therapeutics Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's revenue is 22%. The projected CAGR for the next 3 years is 8%.

22%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's operating income is 16%. The projected CAGR for the next 3 years is 14%.

16%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Vitrolife AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VITR's stock price target?
Price Target
272.85 SEK

According to Wall Street analysts, the average 1-year price target for VITR is 272.85 SEK with a low forecast of 252.5 SEK and a high forecast of 294 SEK.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Vitrolife AB's revenue is 22%. The projected CAGR for the next 3 years is 8%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Vitrolife AB's operating income is 16%. The projected CAGR for the next 3 years is 14%.

Back to Top